- Home
- ANTX vs SER Comparison
ANTX vs SER Comparison
Compare ANTX & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANTX
- SER
- Stock Information
- Founded
- ANTX 2017
- SER 2017
- Country
- ANTX United States
- SER United States
- Employees
- ANTX N/A
- SER N/A
- Industry
- ANTX Biotechnology: Pharmaceutical Preparations
- SER Biotechnology: Pharmaceutical Preparations
- Sector
- ANTX Health Care
- SER Health Care
- Exchange
- ANTX Nasdaq
- SER Nasdaq
- Market Cap
- ANTX 40.0M
- SER 46.7M
- IPO Year
- ANTX 2022
- SER 2018
- Fundamental
- Price
- ANTX $1.44
- SER $5.64
- Analyst Decision
- ANTX Hold
- SER
- Analyst Count
- ANTX 5
- SER 0
- Target Price
- ANTX $3.50
- SER N/A
- AVG Volume (30 Days)
- ANTX 298.6K
- SER 45.6K
- Earning Date
- ANTX 11-13-2024
- SER 11-12-2024
- Dividend Yield
- ANTX N/A
- SER N/A
- EPS Growth
- ANTX N/A
- SER N/A
- EPS
- ANTX N/A
- SER N/A
- Revenue
- ANTX N/A
- SER $3,157,500.00
- Revenue This Year
- ANTX N/A
- SER N/A
- Revenue Next Year
- ANTX N/A
- SER N/A
- P/E Ratio
- ANTX N/A
- SER N/A
- Revenue Growth
- ANTX N/A
- SER 2454.55
- 52 Week Low
- ANTX $0.87
- SER $3.81
- 52 Week High
- ANTX $22.22
- SER $23.18
- Technical
- Relative Strength Index (RSI)
- ANTX 56.85
- SER 53.02
- Support Level
- ANTX $1.23
- SER $4.80
- Resistance Level
- ANTX $1.43
- SER $6.28
- Average True Range (ATR)
- ANTX 0.09
- SER 0.81
- MACD
- ANTX -0.01
- SER 0.09
- Stochastic Oscillator
- ANTX 58.33
- SER 54.38
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases with high unmet needs. The initial product candidate is epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial, or NTM, lung disease.
About SER Serina Therapeutics Inc.
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers.